Lanoxin and Loratadine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lanoxin (digoxin) and Loratadine (loratadine). Common drug interactions include dyspnoea among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Lanoxin and Loratadine. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,314 Loratadine users. Check the latest studies of Loratadine.

On Jul, 16, 2026

85 people who take Lanoxin and Loratadine together, and have interactions are studied.

Lanoxin and Loratadine drug interactions.

What are the common drug interactions of Lanoxin and Loratadine, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Hypoaesthesia (reduced sense of touch or sensation)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Urinary retention (the inability to completely or partially empty the bladder)
Urinary tract infection
Cough
Fatigue (feeling of tiredness)
Hypotension (abnormally low blood pressure)

male:

Dyspnoea (difficult or laboured respiration)
Urticaria (rash of round, red welts on the skin that itch intensely)
Cardiac failure
Headache (pain in head)
Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Anticoagulation drug level above therapeutic
Asthenia (weakness)
Balance disorder
Chronic kidney disease
Constipation

What are the common drug interactions of Lanoxin and Loratadine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Blood pressure increased
Cold sweat
Feeling jittery
Headache (pain in head)
Limb discomfort (discomfort in leg)
Palpitations (feelings or sensations that your heart is pounding or racing)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Vision blurred

30-39:

n/a

40-49:

Epistaxis (bleed from the nose)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hepatomegaly (abnormal enlargement of the liver)
International normalised ratio increased
Liver fatty (fat deposition of liver)
Loss of consciousness

50-59:

Encephalopathy (functioning of the brain is affected by some agent or condition)
Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)
Neuropathy peripheral (surface nerve damage)
Cardiac failure
Cough
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Dizziness
Drug hypersensitivity
Drug ineffective

60+:

Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Cough
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Rash macular (small, flat red spots)
Syncope (loss of consciousness with an inability to maintain postural tone)
Arrhythmia (irregular heartbeat)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Diarrhoea

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 7 people, 8.24%
Dyspnea (difficult or laboured breathing): 6 people, 7.06%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 5.88%
Pain: 5 people, 5.88%
Nausea (feeling of having an urge to vomit): 5 people, 5.88%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 5.88%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and Loratadine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously